Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-03-23
1990-04-03
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, 514445, 514471, 514473, 549 62, 549 65, 549 66, 549479, 546212, 546213, 548527, A61K 3138, A61K 3134, C07D33332, C07D30702
Patent
active
049141112
ABSTRACT:
Thiophene (or furan)-2-sulfonamides with a 4-benzyl substituent are effective in the treatment of elevated intraocular pressure and glaucoma following topical ocular administration.
REFERENCES:
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4416890 (1983-11-01), Woltersdorf, Jr.
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4477466 (1984-10-01), Shepard
patent: 4486444 (1984-12-01), Shepard
patent: 4542152 (1985-09-01), Shepard
patent: 4544667 (1985-10-01), Shepard et al.
patent: 4585787 (1986-04-01), Shepard
patent: 4665090 (1987-05-01), Graham
Halczenko Wasyl
Hartman George D.
DiPrima Joseph F.
Merck & Co. , Inc.
Murray Edward W.
Nicholson William H.
Siegel Alan
LandOfFree
4-Benzylthiophene (or furan)-2-sulfonamides as antiglaucoma agen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Benzylthiophene (or furan)-2-sulfonamides as antiglaucoma agen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Benzylthiophene (or furan)-2-sulfonamides as antiglaucoma agen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1357822